BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 25916739)

  • 1. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
    McAllister SD; Soroceanu L; Desprez PY
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids in the treatment of cancer.
    Alexander A; Smith PF; Rosengren RJ
    Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids as anticancer therapeutic agents.
    Kovalchuk O; Kovalchuk I
    Cell Cycle; 2020 May; 19(9):961-989. PubMed ID: 32249682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Aspects for Cannabinoids in Breast Cancer Therapy.
    Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for the treatment of inflammation.
    Ashton JC
    Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
    Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
    Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cannabinoids Effect on Bone Formation and Bone Healing.
    Raphael-Mizrahi B; Gabet Y
    Curr Osteoporos Rep; 2020 Oct; 18(5):433-438. PubMed ID: 32705630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.